Skip to content

SARS-CoV-2

Optimer™ reagents bind to new COVID-19 variant

We demonstrate that Optimer binders show equivalent binding to both the WT and new COVID-19 variant for continued reliable results in research, diagnostics and therapeutics. Newly emerging, fast-spreading variants of…

Integumen signs MTA with Aptamer Group Ltd

09/07/2020 Collaboration to use aptamers in a device to detect SARS-CoV-2 in wastewater Aptamer Group, developers of Aptamer reagents, is pleased to announce that it has signed…

Aptamers in the battle against COVID19

20th May 2020 Our success continues. Towards the end of last week, we showed that the lab team had successfully isolated a population of aptamers which have preferential…